June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

March 31, 2015March 31, 2015

Melanoma Advocates And Movie Stars Together Against Melanoma

Melanoma, News

The Melanoma Research Foundation (MRF) recently announced the 4th annual Miles for Melanoma 5k Run/Walk on the Universal Studios Backlot, which will take place on May 3rd, 2015. All proceeds from the event will serve to ... Read more

March 30, 2015March 30, 2015

Gene Removal May Help Melanoma Treatment

Melanoma, News

In a new study entitled “Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma” researchers at the Rutgers Cancer Institute, New Jersey show the potential added benefit of combining anti-autophagy ... Read more

March 27, 2015April 3, 2015

Data On IMBRUVICA To Be Presented During 2015 AACR Meeting

Melanoma, News

Pharmacyclics, Inc., a biopharmaceutical company focused on the development and commercialization of innovative small-molecule drugs to treat cancer and immune mediated diseases recently announced that they will present the results ... Read more

March 26, 2015March 26, 2015

DermTech Presents Promising Results During the 2015 American Academy of Dermatology Conference

News

DermTech, Inc., a dermatology company developing non-invasive gene expression tests to aid the clinical diagnosis of skin cancer and other skin conditions, presented their recent work during the 2015 Annual Meeting of the ... Read more

March 25, 2015March 25, 2015

UCLA Researchers Develop Effective Triple Combination Therapy for Melanoma

Melanoma, News

Researchers at the University of California, Los Angeles (UCLA) recently published in the journal Science Translational Medicine results of a groundbreaking effective triple combination therapy for advanced melanoma. The study is ... Read more

March 24, 2015March 24, 2015

How Advanced Melanoma Treatments Can Improve Patient Survival

Melanoma, News

When melanoma is detected early, treatment can be highly successful. However, survival rates decrease significantly when cancer cells spread to the lymph nodes and other organs. In the last 5 years, targeted therapy and ... Read more

March 23, 2015March 23, 2015

Melanoma Mortality Expected to Vanish in Light-Skinned Populations by 2050

News

A reduction in the mortality rate of cutaneous malignant melanoma, the most lethal form of skin cancer, is on the horizon for light-skinned populations, a recent study published in the ... Read more

March 20, 2015March 20, 2015

Research Shows Standard Treatments Not Effective Against Nodal in Metastatic Melanoma

Melanoma, News

A recent study published in Molecular Cancer Research, led by researchers from the laboratory of Mary J.C. Hendrix, found that standard treatments to address metastatic melanoma are ineffective against Nodal, a growth factor protein. ... Read more

March 19, 2015March 19, 2015

Novel Immunotherapy Drug Pembrolizumab ‘Fast-Tracked’ for Advanced Melanoma

Melanoma, News

Under a new United Kingdom Government scheme, the novel immunotherapy drug Pembrolizumab has become the first treatment ‘fast-tracked’ for National Health Service (NHS) patients with advanced melanoma. “It’s a step ... Read more

March 18, 2015March 18, 2015

Macrophages – The Missing Link in Melanoma Resistance to BRAF Therapy

News

In a new study entitled “BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth,” researchers suggest that a specific type of immune cell — macrophages — offers a potential new therapeutic ... Read more

March 17, 2015March 17, 2015

Researchers Discover Genetic Alterations in Children and Adolescents with Melanoma

Melanoma, News

Researchers from the St. Jude Children’s Research Hospital — Washington University Pediatric Cancer Genome Project were able to identify the genetic foundations of three different pediatric melanoma subtypes. These new ... Read more

March 16, 2015March 16, 2015

DermSpectra Nikon D810 Camera Integration Provides a High Resolution Skin Imaging Solution

Melanoma, News

DermSpectra — a startup firm specializing in the field of digital medical imaging systems — has announced a new OEM relationship with Japanese photography and optics Nikon Inc. Under terms ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group